Concurso «Challenge to the Innovation Ecosystem»

EARLY DIAGNOSIS OF CHRONIC KIDNEY DISEASE (CKD) THROUGH INNOVATIVE TECHNOLOGICAL SOLUTIONS

Overview of the Condition
Chronic kidney disease (CKD) is defined by the presence of alterations in renal structure or function for a period of more than 3 months with health consequences, regardless of the cause. It is currently recognized as a major sociosanitary issue that requires a multidisciplinary and integrated approach. It is becoming increasingly relevant due to the morbidity and mortality associated with the patients affected. From a clinical point of view, early detection and diagnosis is essential, as it is a silent pathology, symptoms first start to manifest at advanced stages.

Challenge to the Innovation Ecosystem
At AstraZeneca, we are convinced that technology can improve the prevention of future diseases. The capability of digital technologies to improve early diagnosis is already a reality, and the healthcare sector is rapidly evolving thanks to such disruptive technologies. The wide range of technologies available represent a natural call to action to ensure Chronic Kidney Disease early diagnosis, slowing its progression and ensuring rapid intervene of population at highest risk of CKD, including patients with type 2 diabetes, hypertension, and cardiovascular disease.
This Open innovation call aims to support the development of projects that, through technology, will help reduce the burden of Chronic Kidney Disease thanks to an early diagnosis.